Skip to main content
Log in

Social storm

  • News Feature
  • Published:

From Nature Biotechnology

View current issue Submit your manuscript

The drug industry is struggling to find ways of engaging with consumers on social media. Failure to adapt may bring substantial opportunity costs, argues Virginia Hughes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Pew Research Internet Project. Social Networking Fact Sheet. http://www.pewinternet.org/fact-sheets/social-networking-fact-sheet/ (January 23–26, 2014).

  2. Pew Research Internet Project. Health Online 2013. http://www.pewinternet.org/2013/01/15/health-online-2013/ (January 15, 2013).

  3. Health, I.M.S. Engaging Patients Through Social Media. http://www.imshealth.com/deployedfiles/imshealth/Global/Content/Corporate/IMS%20Health%20Institute/Reports/Secure/IIHI_Social_Media_Report_2014.pdf (January, 2014).

    Google Scholar 

  4. Davies, M. Listening to Consumers in a Highly Regulated Environment. http://www.nielsen.com/content/dam/corporate/us/en/newswire/uploads/2009/11/Nielsen-Online-Healthcare-Practice_Social-Media-Adverse-Event-Reporting_nov09.pdf (Nielson Online, August, 2008).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hughes, V. Social storm. Nat Biotechnol 33, 14–17 (2015). https://doi.org/10.1038/nbt.3106

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt.3106

  • Springer Nature America, Inc.

This article is cited by

Navigation